Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Fullerenes in targeted therapies

Fullerenes in targeted therapies

US Patent 7758889 · Granted Jul 20, 2010

Estimated economic value: $1,206,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Serine protease molecules and therapies2022
Serine protease molecules and therapies2021
Serine protease molecules and therapies2020
Serine protease molecules and therapies2019
Serine protease molecules and therapies2018
Serine protease molecules and therapies2016
Deimmunized gelonin molecules and therapies2016
Serine protease molecules and therapies2015
Carbon nanotube based imaging agents2015
Fullerene compositions and methods for photochemical purification2014
Therapeutic agents comprising pro-apoptotic proteins2013
Modified proteins, designer toxins, and methods of making thereof2012